vs
嘉楠科技(CAN)与礼来(RNA)财务数据对比。点击上方公司名可切换其他公司
嘉楠科技的季度营收约是礼来的1.7倍($20.8M vs $12.5M),嘉楠科技净利率更高(-18.4% vs -1398.3%,领先1379.9%)
嘉楠科技(Canaan Inc.),也以嘉楠耘智之名开展业务,总部位于新加坡,是一家成立于2013年的计算机硬件厂商,由张楠赓创立,核心产品为比特币挖矿专用的区块链服务器与ASIC微处理器,在加密货币挖矿硬件领域拥有深厚技术积累。
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业,在18个国家设有办事处,产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立,品牌名即取自创始人姓名。
CAN vs RNA — 直观对比
营收规模更大
CAN
是对方的1.7倍
$12.5M
净利率更高
CAN
高出1379.9%
-1398.3%
损益表 — Q3 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $20.8M | $12.5M |
| 净利润 | $-3.8M | $-174.4M |
| 毛利率 | 99.9% | — |
| 营业利润率 | -15.9% | -1513.5% |
| 净利率 | -18.4% | -1398.3% |
| 营收同比 | — | 434.0% |
| 净利润同比 | — | -117.0% |
| 每股收益(稀释后) | $-0.05 | $-1.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CAN
RNA
| Q4 25 | $20.8M | — | ||
| Q3 25 | $13.8M | $12.5M | ||
| Q2 25 | $11.4M | $3.8M | ||
| Q1 25 | — | $1.6M | ||
| Q4 24 | — | $3.0M | ||
| Q3 24 | $10.2M | $2.3M | ||
| Q2 24 | $4.8M | $2.0M | ||
| Q1 24 | — | $3.5M |
净利润
CAN
RNA
| Q4 25 | $-3.8M | — | ||
| Q3 25 | $-1.5M | $-174.4M | ||
| Q2 25 | $-11.9M | $-157.3M | ||
| Q1 25 | — | $-115.8M | ||
| Q4 24 | — | $-102.3M | ||
| Q3 24 | $-10.4M | $-80.4M | ||
| Q2 24 | $-5.4M | $-70.8M | ||
| Q1 24 | — | $-68.9M |
毛利率
CAN
RNA
| Q4 25 | 99.9% | — | ||
| Q3 25 | 99.9% | — | ||
| Q2 25 | 99.9% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 99.9% | — | ||
| Q2 24 | 99.8% | — | ||
| Q1 24 | — | — |
营业利润率
CAN
RNA
| Q4 25 | -15.9% | — | ||
| Q3 25 | -27.0% | -1513.5% | ||
| Q2 25 | -45.5% | -4448.7% | ||
| Q1 25 | — | -8360.9% | ||
| Q4 24 | — | -4069.6% | ||
| Q3 24 | -77.2% | -4200.9% | ||
| Q2 24 | -193.9% | -4040.4% | ||
| Q1 24 | — | -2178.6% |
净利率
CAN
RNA
| Q4 25 | -18.4% | — | ||
| Q3 25 | -11.0% | -1398.3% | ||
| Q2 25 | -104.4% | -4089.3% | ||
| Q1 25 | — | -7360.0% | ||
| Q4 24 | — | -3439.5% | ||
| Q3 24 | -102.7% | -3441.7% | ||
| Q2 24 | -112.3% | -3461.8% | ||
| Q1 24 | — | -1943.4% |
每股收益(稀释后)
CAN
RNA
| Q4 25 | $-0.05 | — | ||
| Q3 25 | $-0.02 | $-1.27 | ||
| Q2 25 | $-0.25 | $-1.21 | ||
| Q1 25 | — | $-0.90 | ||
| Q4 24 | — | $-0.80 | ||
| Q3 24 | — | $-0.65 | ||
| Q2 24 | — | $-0.65 | ||
| Q1 24 | — | $-0.79 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $350.2M |
| 总债务越低越好 | $6.2M | — |
| 股东权益账面价值 | $52.4M | $1.9B |
| 总资产 | $92.5M | $2.1B |
| 负债/权益比越低杠杆越低 | 0.12× | — |
8季度趋势,按日历期对齐
现金及短期投资
CAN
RNA
| Q4 25 | — | — | ||
| Q3 25 | — | $350.2M | ||
| Q2 25 | — | $243.9M | ||
| Q1 25 | — | $254.2M | ||
| Q4 24 | — | $219.9M | ||
| Q3 24 | — | $370.2M | ||
| Q2 24 | — | $575.8M | ||
| Q1 24 | — | $471.4M |
总债务
CAN
RNA
| Q4 25 | $6.2M | — | ||
| Q3 25 | $6.2M | — | ||
| Q2 25 | $6.2M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
CAN
RNA
| Q4 25 | $52.4M | — | ||
| Q3 25 | $44.7M | $1.9B | ||
| Q2 25 | $33.8M | $1.2B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | $43.6M | $1.5B | ||
| Q2 24 | $56.8M | $1.2B | ||
| Q1 24 | — | $830.9M |
总资产
CAN
RNA
| Q4 25 | $92.5M | — | ||
| Q3 25 | $81.7M | $2.1B | ||
| Q2 25 | $78.0M | $1.4B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | $69.3M | $1.6B | ||
| Q2 24 | $73.7M | $1.3B | ||
| Q1 24 | — | $951.5M |
负债/权益比
CAN
RNA
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $-156.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-156.9M |
| 自由现金流率自由现金流/营收 | — | -1257.6% |
| 资本支出强度资本支出/营收 | — | 5.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-592.3M |
8季度趋势,按日历期对齐
经营现金流
CAN
RNA
| Q4 25 | — | — | ||
| Q3 25 | — | $-156.2M | ||
| Q2 25 | — | $-199.7M | ||
| Q1 25 | — | $-124.8M | ||
| Q4 24 | — | $-99.9M | ||
| Q3 24 | — | $-65.6M | ||
| Q2 24 | — | $-65.0M | ||
| Q1 24 | — | $-70.4M |
自由现金流
CAN
RNA
| Q4 25 | — | — | ||
| Q3 25 | — | $-156.9M | ||
| Q2 25 | — | $-203.0M | ||
| Q1 25 | — | $-128.6M | ||
| Q4 24 | — | $-103.8M | ||
| Q3 24 | — | $-67.3M | ||
| Q2 24 | — | $-65.5M | ||
| Q1 24 | — | $-71.3M |
自由现金流率
CAN
RNA
| Q4 25 | — | — | ||
| Q3 25 | — | -1257.6% | ||
| Q2 25 | — | -5277.1% | ||
| Q1 25 | — | -8174.3% | ||
| Q4 24 | — | -3491.0% | ||
| Q3 24 | — | -2881.8% | ||
| Q2 24 | — | -3204.6% | ||
| Q1 24 | — | -2012.3% |
资本支出强度
CAN
RNA
| Q4 25 | — | — | ||
| Q3 25 | — | 5.7% | ||
| Q2 25 | — | 86.9% | ||
| Q1 25 | — | 238.6% | ||
| Q4 24 | — | 131.7% | ||
| Q3 24 | — | 72.9% | ||
| Q2 24 | — | 26.0% | ||
| Q1 24 | — | 25.8% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图